Clustering data with hclust algorithm for Statin Immuno-Metabolomics in Asthma (part I) (Study ST000843)
Reversed phase POSITIVE ION MODE (Analysis AN001365)| Metabolite | Structure | F1 | F2 | F3 | F4 | F5 | F6 | F7 | F8 | F9 | F10 | F11 | F12 | F13 | F14 | F15 | F16 | F17 | F18 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| aLEA | ME224443 | 0.89 | 1.06 | 0.94 | 0.53 | 0.59 | 0.35 | NA | NA | NA | NA | NA | NA | 1.77 | 1.30 | 1.06 | 1.30 | 1.18 | 0.83 |
| PEA | ME224439 | 0.64 | 0.68 | 1.18 | 0.84 | 1.07 | 1.02 | 0.20 | 0.20 | 0.20 | 0.19 | 0.18 | 0.17 | 1.76 | 1.22 | 1.49 | 1.79 | 2.48 | 2.43 |
| SEA | ME224440 | 0.74 | 1.19 | 0.88 | 0.74 | 0.59 | 1.21 | 0.12 | 0.21 | 0.08 | 0.12 | 0.16 | 0.10 | 2.51 | 1.57 | 0.86 | 1.15 | 2.62 | 3.12 |
| LTE4 | ME224459 | 1.17 | 0.29 | 0.54 | 1.06 | 1.16 | 0.85 | 0.81 | 1.49 | 0.78 | 0.51 | 1.31 | 0.95 | NA | NA | NA | NA | NA | NA |
| 1-AG | ME224437 | 1.19 | 0.83 | 0.90 | 1.22 | 0.91 | 0.33 | 1.89 | 1.22 | 2.25 | 1.90 | 2.33 | 1.43 | 0.69 | 0.42 | 0.53 | 0.34 | 0.46 | 0.42 |
| 1-LG | ME224435 | 0.92 | 0.83 | 0.86 | 1.07 | 1.57 | 0.38 | 1.55 | 0.90 | 1.98 | 1.79 | 1.44 | 0.81 | 0.96 | 0.52 | 0.86 | 0.46 | 0.87 | 0.69 |
| NO-Gly | ME224450 | 0.77 | 0.60 | 1.93 | 1.06 | 0.93 | 0.73 | 0.81 | 1.53 | 1.19 | 2.21 | 0.86 | 0.95 | 0.71 | 0.72 | 0.69 | 0.47 | 0.92 | 0.68 |
| Dihomo GLA EA | ME224444 | 1.63 | 1.59 | 1.57 | 0.67 | 0.87 | 0.55 | 2.45 | 0.92 | 0.84 | 0.51 | 0.97 | 0.26 | 1.18 | 0.90 | 0.84 | 0.71 | 0.73 | 0.51 |
| 2-LG | ME224436 | 0.68 | 1.06 | 1.49 | 0.88 | 1.89 | 0.39 | 1.60 | 0.60 | 1.05 | 0.95 | 1.04 | 0.82 | 0.92 | 0.85 | 0.82 | 0.62 | 0.66 | 1.19 |
| 2-OG | ME224434 | 0.77 | 1.02 | 1.68 | 1.20 | 1.13 | 0.55 | 2.17 | 0.59 | 1.21 | 1.47 | 0.92 | 0.76 | 0.72 | 0.69 | 0.73 | 0.49 | 0.55 | 1.23 |
| 1-OG | ME224433 | 0.62 | 1.01 | 1.17 | 0.97 | 1.36 | 0.58 | 1.81 | 0.99 | 0.90 | 2.11 | 0.99 | 0.73 | 0.85 | 0.63 | 0.85 | 0.70 | 1.22 | 0.72 |
| DEA | ME224446 | 1.64 | 1.07 | 1.24 | 1.14 | 0.95 | 0.36 | 1.65 | 0.96 | 0.90 | 2.22 | 0.99 | 0.56 | 0.80 | 0.87 | 0.79 | 0.56 | 0.64 | 0.67 |
| DHEA | ME224447 | 0.82 | 0.92 | 1.22 | 0.78 | 0.59 | 0.46 | 2.55 | 1.64 | 1.22 | 1.48 | 1.02 | 0.79 | 1.16 | 1.12 | 1.07 | 0.67 | 1.06 | 0.88 |
| AEA | ME224445 | 1.24 | 1.11 | 1.13 | 1.51 | 0.62 | 0.43 | 2.63 | 1.31 | 1.03 | 1.76 | 1.01 | 0.90 | 0.89 | 0.89 | 0.71 | 0.55 | 0.64 | 0.46 |
| LEA | ME224442 | 1.00 | 0.87 | 1.10 | 1.23 | 0.68 | 0.52 | 1.95 | 1.18 | 1.26 | 1.92 | 1.15 | 0.96 | 1.01 | 1.01 | 0.91 | 0.66 | 0.85 | 0.72 |
| 2-AG | ME224438 | 0.87 | 0.98 | 1.33 | 1.01 | 0.89 | 0.49 | 2.04 | 1.17 | 1.17 | 0.96 | 1.63 | 1.09 | 1.10 | 0.90 | 0.73 | 0.69 | 0.67 | 1.03 |
| OEA | ME224441 | 0.97 | 0.93 | 1.16 | 1.10 | 0.68 | 0.58 | 1.63 | 0.95 | 0.97 | 1.15 | 0.96 | 0.89 | 1.25 | 1.21 | 1.34 | 0.84 | 1.15 | 1.01 |
Factors:
| F1 | Treatment:Control | Lung:Left Lung | Time point (day):- |
| F2 | Treatment:Control | Lung:Left Lung | Time point (day):12 |
| F3 | Treatment:Control | Lung:Left Lung | Time point (day):8 |
| F4 | Treatment:Control | Lung:Right Lung | Time point (day):- |
| F5 | Treatment:Control | Lung:Right Lung | Time point (day):12 |
| F6 | Treatment:Control | Lung:Right Lung | Time point (day):8 |
| F7 | Treatment:Pravastatin | Lung:Left Lung | Time point (day):- |
| F8 | Treatment:Pravastatin | Lung:Left Lung | Time point (day):12 |
| F9 | Treatment:Pravastatin | Lung:Left Lung | Time point (day):8 |
| F10 | Treatment:Pravastatin | Lung:Right Lung | Time point (day):- |
| F11 | Treatment:Pravastatin | Lung:Right Lung | Time point (day):12 |
| F12 | Treatment:Pravastatin | Lung:Right Lung | Time point (day):8 |
| F13 | Treatment:Simvastatin | Lung:Left Lung | Time point (day):- |
| F14 | Treatment:Simvastatin | Lung:Left Lung | Time point (day):12 |
| F15 | Treatment:Simvastatin | Lung:Left Lung | Time point (day):8 |
| F16 | Treatment:Simvastatin | Lung:Right Lung | Time point (day):- |
| F17 | Treatment:Simvastatin | Lung:Right Lung | Time point (day):12 |
| F18 | Treatment:Simvastatin | Lung:Right Lung | Time point (day):8 |
